Alex Sverdlov PhD

Alex Sverdlov is a Senior Director, Statistical Scientist at Novartis. He earned his B.Sc. in Applied Mathematics from V.N. Karazin Kharkiv National University, Ukraine, in 2001, M.Sc. in Statistics from the University of Maryland, Baltimore County in 2004, and Ph.D. in Information Technology with Concentration in Statistical Science from George Mason University in 2007. Over the past 17 years, Alex has been actively involved in methodological research and applications of innovative statistical approaches in drug development.

He has co-authored over fifty refereed articles, a book ``Mathematical and Statistical Skills in the Biopharmaceutical Industry: A Pragmatic Approach'' (CRC Press/Chapman & Hall, 2019), and three monographs, including “Digital Therapeutics: Strategic, Scientific, Developmental, and Regulatory Aspects” (CRC Press/Chapman & Hall, 2022). His most recent work involves the design and analysis of clinical trials evaluating novel digital technologies.